| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8440526 | European Journal of Cancer | 2018 | 10 Pages |
Abstract
AI treatment, preferably without any TAM treatment, was associated with the best RFS and OS outcome in ER+/HER2+ perimenopausal breast cancer patients.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
G.M.H.E. Dackus, K. Jóźwiak, G.S. Sonke, E. van der Wall, P.J. van Diest, M. Hauptmann, S. Siesling, S.C. Linn,